TGFB1 and Hepatic fibrosis: Our finding is the first to show that 1-PHE may suppress HSC activation induced by TGF-β1, possibly through modulation of the Wnt/β-catenin signaling pathway, given that inhibition of Wnt/β-catenin signaling is a recognized therapeutic strategy for liver fibrosis [29,30].